NEWS & EVENTS
NIBIB grantees Jason Burdick and Robert Mauck at the University of Pennsylvania have found a way to coax stem cells to differentiate into cartilage-producing cells by encapsulating them in gels that contain cadherin molecules. The technique could be used to increase the efficiency of stem cell transplants used to repair injured or deteriorating cartilage. Read the full article on ScienceDaily.com
NIBIB grantee Bin He, of the University of Minnesota, and team demonstrate their noninvasive brain-computer interface that allows precise, thought-guided movements of a toy helicopter. Such interfaces may someday lead to mind-controlled assistive devices for people who have been paralyzed. Read the full article on usnews.com
Imagine being able to redirect powerful immune cells to fight cancer. How about reprogramming a diabetic’s skin cell into a cell that could manufacture the insulin their pancreas no longer produces? Could we dial down the production of fat cells in obese adolescents? These are major health problems and medical challenges that may be more achievable with a new fundamental technology that gets vital control molecules into cells faster, safer, and more effectively.
Previous NIBIB DEBUT contest winners continue to develop their award-winning low-cost, pocket-sized spirometer with a goal of revolutionizing the way asthma and other chronic respiratory diseases are diagnosed and treated. Read full article on wustl.edu
Several NIBIB grantees (Donoghue, Kirsch, Tyler,) and their research are noted in this discussion of how prosthetic arms are becoming more and more sophisticated. Recent developments incorporating a sense of touch are highlighted. Read the full article on Nature.com.
NIH researchers funded by NIBIB, NICHD, NINDS, and NIMH discuss the latest in thought-controlled prostheses and robotic technologies that are designed to assist the disabled, including stroke victims, the paralyzed, or those with missing limbs. Read the full article from The Washington Post.
NIBIB grantee, Ralph Weissleder at Massachusetts General Hospital, has developed the ability to rapidly diagnose tuberculosis (TB) and antibiotic-resistant bacterial strains using the handheld microfluidic device created to diagnose cancer. The device combines microfluidic technology and nuclear magnetic resonance (NMR) to diagnose TB in two to three hours. Read the full article from ScienceDaily.
A profile of Sangeeta Bhatia, NIBIB-funded researcher at the Massachusetts Institute of Technology highlights her bioengineering research achievements. The article also mentions other notable NIBIB-funded researchers, such as Christopher Chen, Jennifer Elisseeff, Robert Langer, and Mehmet Toner. Read the full article from TheScientist.
NIBIB-funded researcher Reinhard Schulte from Loma Linda University in Loma Linda, California describes how the emergence of proton CT could improve the precision of proton delivery. Read the full article at MedicalPhysicsWeb.